The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines

被引：31

作者：

Assudani, Deepak P. ^{[1
]}

Horton, Roger B. V. ^{[1
]}

Mathieu, Morgan G. ^{[1
]}

McArdle, Stephanie E. B. ^{[1
]}

Rees, Robert C. ^{[1
]}

机构：

[1] Nottingham Trent Univ, Sch Biomed & Nat Sci, Nottingham NG11 8NS, England

来源：

CANCER IMMUNOLOGY IMMUNOTHERAPY | 2007年 / 56卷 / 01期

关键词：

D O I：

10.1007/s00262-006-0154-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recent years have seen the unprecedented surge of interest in the role of CD4+ T cells and the role they play in the development of the immune response. In this symposium review, we examine the evidence for this and discuss their functions, particularly in respect to the cancer immunology, including CD4+CD25+ cells (Treg).

引用

页码：70 / 80

页数：11

共 104 条

[1] DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction [J].

Adam, C ;

King, S ;

Allgeier, T ;

Braumüller, H ;

Lüking, C ;

Mysliwietz, J ;

Kriegeskorte, A ;

Busch, DH ;

Röcken, M ;

Mocikat, R .

BLOOD, 2005, 106 (01) :338-344

[2] Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSF [J].

Ahmad, M ;

Rees, RC ;

McArdle, SE ;

Li, G ;

Mian, S ;

Entwisle, C ;

Loudon, P ;

Ali, SA .

INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (06) :951-959

[3] Escape from immunotherapy: possible mechanisms that influence tumor regression/progression [J].

Ahmad, M ;

Rees, RC ;

Ali, SA .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (10) :844-854

[4] IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients [J].

Ahmadzadeh, M ;

Rosenberg, ST .

BLOOD, 2006, 107 (06) :2409-2414

[5] Anti-tumour therapeutic efficacy of OX40L in murine tumour model [J].

Ali, SA ;

Ahmad, M ;

Lynam, J ;

McLean, CS ;

Entwisle, C ;

Loudon, P ;

Choolun, E ;

McArdle, SEB ;

Li, G ;

Mian, S ;

Rees, RC .

VACCINE, 2004, 22 (27-28) :3585-3594

[6] Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity [J].

Ali, SA ;

Lynam, J ;

McLean, CS ;

Entwisle, C ;

Loudon, P ;

Rojas, JM ;

McArdle, SEB ;

Li, G ;

Mian, S ;

Rees, RC .

JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3512-3519

[7] The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs [J].

Allan, SE ;

Passerini, L ;

Bacchetta, R ;

Crellin, N ;

Dai, MY ;

Orban, PC ;

Ziegler, SF ;

Roncarolo, MG ;

Levings, MK .

JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3276-3284

[8]

[Anonymous], 1985, AM J COS SURG

[9]

ASSUDANI DP, 2005, CANCER IMMUNOL IMMUN, V6, P1

[10] TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation [J].

Bachmann, MF ;

Wong, BR ;

Josien, R ;

Steinman, RM ;

Oxenius, A ;

Choi, Y .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1025-1031

← 1 2 3 4 5 6 7 8 9 10 →